Cytel

Overview

Cytel is a contract research organization specializing in data science, statistical analysis, and advanced analytics for pharmaceutical and biotech clients. Founded in 1987 by Cyrus Mehta and Nitin Patel, the company combines expertise in statistical design, clinical development, trial deployment, regulatory strategy, and commercialization.

Core Services

Discovery & Early Development

• Tailored analytics to guide strategic decisions and accelerate early-stage drug development
• Preclinical solutions with cutting-edge analytics and insights

Clinical Trial Services (Phase I–III)

• Clinical trial design with advanced analytical methods
• Adaptive trial design and complex/innovative trial design
• Trial delivery and data-driven strategies to navigate trial complexities
• End-to-end biometrics and data management
• Clinical development strategy and planning
• Model-informed drug development
• Clinical pharmacology, drug metabolism, and pharmacokinetics support
• Axio® Data Monitoring Committee solutions
• Simulation-based clinical trial enrollment forecasting (Enforesys®)

Commercialization & Post-Market

• Market access and health economics and outcomes research (HEOR)
• Regulatory strategy consulting
• Real-world evidence solutions and real-world data analytics
• Post-authorization safety studies
• Health and technology assessments

Functional Service Provider (FSP) Model

• Scalable teams of experts that integrate into client processes

Regulatory & Analytical Capabilities

Cytel supports clients across the full drug development lifecycle with data-driven decision-making from conception to commercialization, including regulatory submissions and post-market surveillance.